Clinical Trial Update: Melatonin for Circadian Sleep Disorders in the Blind [NA]

View source ↗

Summary

Clinical trial update on melatonin for circadian sleep disorders in the blind; study terminated with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blindness
• Daytime Sleepiness
• Insomnia

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Insomnia, Blindness | NA | Status: TERMINATED | Results posted: 2019-11-27